Association between transfusion of stored blood and infective bacterial complications after resection for colorectal cancer

European Journal of Surgery

Volumn 164, Issue 6, 1998, Pages 449-456

  Edna, Tom Harald ^a   Bjerkeset, Tormod ^a  

^a Innherred Hospital   (Norway)

Author keywords

Adenocarcinoma surgery; Bacterial infections etiology; Blood transfusion adverse effects; Colorectal neoplasms surgery; Human; Retrospective studies; Risk factors

Indexed keywords

AMPICILLIN; DOXYCYCLINE; METRONIDAZOLE;

ABDOMINAL ABSCESS; ADENOCARCINOMA; ADULT; AGE; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BLEEDING; BLOOD STORAGE; BLOOD TRANSFUSION; CANCER RADIOTHERAPY; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NORWAY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; URINARY TRACT INFECTION; WOUND INFECTION;

ADENOCARCINOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; BLOOD PRESERVATION; BLOOD TRANSFUSION; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0031805982     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241598750004265     Document Type: Article

References (36)

1. Agarwal N, Murphy JG, Cayten CG, Stahl WM. Blood transfusion increases the risk of infection after trauma. Arch Surg 1993; 128: 171-176.
2. Blumberg N, Heal JM. Effects of transfusion on immune function. Arch Pathol Lab Med 1994; 118: 371-379.
3. Blajchman MA, Bordin JO. The tumor growth-promoting effect of allogeneic blood transfusions. Immunol Invest 1995; 24: 311-317.
4. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84: 1703-1721.
5. Bordin JO, Blajchman MA. Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy. Hematol Oncol Clin North Am 1995; 9: 205-218.
6. Braga M, Vignali A, Radaelli G, Gianotti L, Di Carlo V. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. Eur J Surg 1992; 158: 531-536.
7. Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-1376.
8. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection of colorectal carcinoma. Br J Surg 1993; 80; 427-432.
9. Edna T-H, Vada K, Hesselberg F, Mjølnerød OK. Blood transfusion and survival following surgery for renal carcinoma. Br J Urol 1992; 21: 1165-1167.
10. Edna T-H, Bjerkeset T. Association between blood transfusion and infection in injured patients. J Trauma 1992; 33: 659-661.
11. Edna T-H, Bjerkeset T, Svinsås M, Drogset JO, Skreden K. Association between transfusion of stored blood and bacterial infective complications after biliary operations. Eur J Surg 1994; 160: 357-362.
12. Faris P. Use of recombinant human erythropoietin in the perioperative period of orthopedic surgery. Am J Med 1996; 101: 28S-32S.
13. Ford CD, VanMoorleghem G, Menlove RL. Blood transfusion and postoperative wound infection. Surgery 1993; 113: 603-607.
14. Gombotz H. Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary bypass graft surgery. Semin Hematol 1996; 33: 69-70.
15. Heiss MM, Mempel W, Jauch K-W, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993; 342: 1328-1333.
16. Heiss MM, Tarabichi A, Delanoff C, et al. Perisurgical erythropoietin application in anemic patients with colorectal cancer: a double-blind randomised study. Surgery 1996; 119: 523-527.
17. Houbiers JGA, Busch ORC, Van de Watering LMG, et al. Blood transfusion in cancer surgery: a consensus statement. Eur J Surg 1995; 161: 307-314.
18. Hosmer DW, Lemeshow SL Applied logistic regression. New York: John Wiley 1989.
19. Jeekel J. Autologous blood donation and epoetin alfa in cancer surgery. Semin Hematol 1996; 33: 43-46.
20. Jensen LS, Kissmeyer-Nielsen Å, Wolff B, Qvist N. Randomized comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348: 841-845.
21. Klein HG. Immunologic aspects of blood transfusion. Semin Oncol 1994; 21: 16-20.
22. Kreimeier U, Messmer K. Hemodilution in clinical surgery: state of the art. World J Surg 1996; 20: 1208-1217.
23. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ 1991; 302: 1501-1505.
24. Messmer K. Round table of experts in surgery blood management - consensus statement. Infusionsther Transfusionsmed 1996; 23: 143-146.
25. Mielke LL, Entholzner EK, Kling M, et al. Preoperative acute hypervolemic hemodilution with hydroxyethyl starch: an alternative to acute normovolemic hemodilution? Anesth Analg 1997; 84: 26-30.
26. Murphy PJ, Connery C, Hicks Jr GL, Blumberg N. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operation. J Thorac Cardiovasc Surg 1992; 104: 1092-1099.
27. Nielsen HJ, Reimert CM, Pedersen AN, et al. Time-dependent, spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 1996; 36: 960-965.
28. Nielsen HJ, Reimert CM, Dybkjær E, Røed J, Alsbjørn B. Bioactive substance accumulation and septic complications in a burn trauma patient: effect of perioperative blood transfusion? Burns 1997; 23: 59-63.
29. Norfolk DR, Williamson LM. Leucodepletion of blood products by filtration. Blood Rev 1995; 9: 7-14.
30. Oberhauser M, Bardenheuer HJ, Bernasconi H, Genz T, Kreimeier U. Isovolämische Hämodilution (IHD) zur Einsparung von Fremdbluttransfusionen: Effektivität bei grossen gynäkologischen Eingriffen. Infusionsther Transfusionsmed 1996; 23: 15-23.
31. Sowade O, Warnke H, Scigalle P, et al. Avoidance of allogeneic blood transfusion by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997; 89: 411-418.
32. Spahn DR, Zollinger A, Schlumpf RB, et al. Hemodilution tolerance in elderly patients without known cardiac disease. Anesth Analg 1996; 82: 681-686.
33. Tartter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg 1988; 75: 789-792.
34. Voogt PJ, van der Velde CJ, Brand A, et al. Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer 1987; 59: 836-843.
35. Walpoth B, Galliker B, Spirig P et al. Use of epoetin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery. Semin Hematol 1996; 33: 75-76.
36. Wolters U, Stutzer H, Keller HW, Schroder U, Pichlmaier H. Colorectal cancer - a multivariate analysis of prognostic factors. Eur J Surg Oncol 1996; 22: 592-597.